These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Lapiz MD; Morilak DA Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081 [TBL] [Abstract][Full Text] [Related]
83. Ameliorative effect of traditional Japanese medicine yokukansan on age-related impairments of working memory and reversal learning in rats. Mizoguchi K; Shoji H; Tanaka Y; Tabira T Neuroscience; 2011 Mar; 177():127-37. PubMed ID: 21195139 [TBL] [Abstract][Full Text] [Related]
84. A sensitizing regimen of amphetamine that disrupts attentional set-shifting does not disrupt working or long-term memory. Featherstone RE; Rizos Z; Kapur S; Fletcher PJ Behav Brain Res; 2008 May; 189(1):170-9. PubMed ID: 18299157 [TBL] [Abstract][Full Text] [Related]
85. An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function. Fone KC Neuropharmacology; 2008 Nov; 55(6):1015-22. PubMed ID: 18655798 [TBL] [Abstract][Full Text] [Related]
86. Attentional set-shifting in rodents: a review of behavioural methods and pharmacological results. Tait DS; Chase EA; Brown VJ Curr Pharm Des; 2014; 20(31):5046-59. PubMed ID: 24345263 [TBL] [Abstract][Full Text] [Related]